AN2 Therapeutics Inc.
ANTX | NASDAQ
$4.53
-$0.16 (-3.41%)
At close: Oct 30, 2026, 4:00 PM ET
$4.54
+$0.01 (+0.22%)
Pre-market:
Nov 2, 2026, 9:06 AM ET
TTM Period Ending | TTM 2026 Jun 30, 2026 | TTM 2026 Mar 31, 2026 | TTM 2025 Dec 31, 2025 | TTM 2025 Sep 30, 2025 | TTM 2025 Jun 30, 2025 | TTM 2025 Mar 31, 2025 | TTM 2024 Dec 31, 2024 | TTM 2024 Sep 30, 2024 | TTM 2024 Jun 30, 2024 | TTM 2024 Mar 31, 2024 | TTM 2023 Dec 31, 2023 | TTM 2023 Sep 30, 2023 | TTM 2023 Jun 30, 2023 | TTM 2023 Mar 31, 2023 | TTM 2022 Dec 31, 2022 | TTM 2022 Sep 30, 2022 | TTM 2022 Jun 30, 2022 | TTM 2022 Mar 31, 2022 | TTM 2021 Dec 31, 2021 | TTM 2021 Sep 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PE Ratio | -4.52 | -3.11 | -0.98 | -1.13 | -0.85 | -0.90 | -0.80 | -0.52 | -0.94 | -1.45 | -7.48 | -5.60 | -3.06 | -3.96 | -3.42 | -9.15 | -3.93 | -7.77 | -10.27 | -11.67 |
PEG Ratio | 0.12 | n/a | 0.03 | -0.02 | 0.02 | -0.02 | 0.02 | 0.05 | 0.07 | 0.83 | 4.17 | 0.28 | -0.38 | -0.29 | -0.04 | -1.19 | -0.13 | 1.63 | -0.11 | -0.41 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 2.85 | 1.42 | 0.65 | 0.64 | 0.46 | 0.56 | 0.50 | 0.36 | 0.65 | 1.01 | 3.88 | 2.97 | 1.89 | 2.32 | 1.53 | 3.19 | 1.29 | 2.48 | 4.66 | n/a |
P/FCF Ratio | -7.06 | -3.72 | -1.15 | -1.29 | -0.90 | -0.97 | -0.84 | -0.52 | -1.04 | -1.89 | -9.07 | -9.40 | -3.99 | -4.99 | -4.37 | -9.66 | -4.97 | -11.15 | -14.09 | -18.83 |
P/OCF Ratio | -7.06 | -3.72 | -1.15 | -1.29 | -0.90 | -0.97 | -0.84 | -0.52 | -1.04 | -1.89 | -9.07 | -9.40 | -3.99 | -4.99 | -4.37 | -9.66 | -4.97 | -11.15 | -14.09 | -18.83 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0 | 0 | 0 | 0 | 0 | 0 | n/a | n/a |
Quick Ratio | 14.32 | 15.73 | 6.87 | 9.33 | 31.96 | 8.68 | 8.43 | 9.75 | 10.61 | 10.91 | 7.87 | 8.52 | 8.80 | 10.54 | 13.72 | 24.21 | 28.17 | 23.55 | 17.70 | n/a |
Current Ratio | 14.32 | 15.73 | 6.87 | 9.33 | 31.96 | 8.68 | 8.43 | 9.75 | 10.61 | 10.91 | 7.87 | 8.52 | 8.80 | 10.54 | 13.72 | 24.21 | 28.17 | 23.55 | 17.70 | n/a |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -82.22 | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -53.52% | -52.35% | -55.04% | -47.80% | -47.97% | -53.17% | -54.24% | -57.63% | -54.72% | -57.16% | -59.67% | -58.99% | -58.52% | -48.71% | -37.90% | -36.77% | -33.01% | -30.62% | -66.64% | -74.45% |
Return on Assets | -44.41% | -39.49% | -56.78% | -50.55% | -49.30% | -55.76% | -55.73% | -62.13% | -59.60% | -54.45% | -46.66% | -38.80% | -54.90% | -53.38% | -39.93% | -33.32% | -26.88% | -22.53% | -32.98% | n/a |
Return on Invested Capital | -40.38% | -35.87% | -56.74% | -48.92% | -47.47% | -53.90% | -54.81% | -60.38% | -57.17% | -51.35% | -44.11% | -35.98% | -51.20% | -48.44% | -34.99% | -27.95% | -22.19% | -18.62% | -27.53% | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove ANTX